cd164 Search Results


94
Sino Biological cd164
Cd164, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd164/Human+CD164+%2F+Endolyn+Protein/pmc04176022-43-43-47
Average 94 stars, based on 1 article reviews
cd164 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
OriGene cdnas
Cdnas, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd164/Cd164+(NM_016898)+Mouse+Tagged+ORF+Clone/pmc09239079-193-11-10
Average 90 stars, based on 1 article reviews
cdnas - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
OriGene human cd164
(A) Schematic of CRISPR-based KO screen done in A549 lung epithelial cells for the identification of LCMV host factors. (B) Gene enrichment for CRISPR screen of rLCMV-mCherry infection. Enrichment scores were determined by MaGECK analysis and genes were colored by biological function. Dotted line indicates −log10(Enrichment Score) = 4. All genes and their enrichment scores can be found in Table S1 . (C) Percentage of infected cells as determined by flow cytometry following infection of A549 homozygous knockouts <t>(CD164,</t> SPR14, IL2RA, KHNYN) or heterozygous knockouts (ARFRP1, YKT6, ACKR4, RAB10, EMC1, SYS1) with rLCMV-mCherry. Wildtype cells were used as normalization controls. Cells were infected at MOI 1 and harvested at 24 hpi. Error bars indicate standard error of three independent experiments. (D) Quantification of viral infection in WT, Δ CD164 , Δ CD164 complemented with human CD164 (Δ CD164 + hCD164 ), and Δ CD164 complemented with mouse Cd164 (Δ CD164 + mCd164 ) in A549, 293T, and 3T6 cell type backgrounds. Cells were infected with rLCMV-mCherry at MOI 1 and harvested at 24 hpi. Error bars indicate standard error of three independent experiments.
Human Cd164, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd164/CD164+(NM_006016)+Human+Tagged+ORF+Clone/bio_rxiv__2022__01__24__477570-176-0-2
Average 90 stars, based on 1 article reviews
human cd164 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
R&D Systems anti human cd164 apc
(A) Schematic of CRISPR-based KO screen done in A549 lung epithelial cells for the identification of LCMV host factors. (B) Gene enrichment for CRISPR screen of rLCMV-mCherry infection. Enrichment scores were determined by MaGECK analysis and genes were colored by biological function. Dotted line indicates −log10(Enrichment Score) = 4. All genes and their enrichment scores can be found in Table S1 . (C) Percentage of infected cells as determined by flow cytometry following infection of A549 homozygous knockouts <t>(CD164,</t> SPR14, IL2RA, KHNYN) or heterozygous knockouts (ARFRP1, YKT6, ACKR4, RAB10, EMC1, SYS1) with rLCMV-mCherry. Wildtype cells were used as normalization controls. Cells were infected at MOI 1 and harvested at 24 hpi. Error bars indicate standard error of three independent experiments. (D) Quantification of viral infection in WT, Δ CD164 , Δ CD164 complemented with human CD164 (Δ CD164 + hCD164 ), and Δ CD164 complemented with mouse Cd164 (Δ CD164 + mCd164 ) in A549, 293T, and 3T6 cell type backgrounds. Cells were infected with rLCMV-mCherry at MOI 1 and harvested at 24 hpi. Error bars indicate standard error of three independent experiments.
Anti Human Cd164 Apc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd164/Human+CD164+Antibody/pmc05589567-199-20-22
Average 93 stars, based on 1 article reviews
anti human cd164 apc - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Proteintech cd164
Fig. 5 ZON represses <t>CD164</t> by enhancing miR-506-3p. A Expression of miR-506-3p was measured by qPCR in cervical cancer cells treated with ZON. B Wild type and mutant binding sites of CD164 with miR-506-3p. C, D Cervical cancer cells were treated with miR-506-3p mimic. C Luciferase activity of CD164 was detected by dual luciferase reporter gene assays. D Expression of CD164 was analyzed by qPCR. E Expression of CD164 was determined by Western blot in the cervical cancer cells. The experiments were repeated 3 times, **P < 0.01
Cd164, supplied by Proteintech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd164/CD164+Antibody/10__1186_slash_s12645___022___00134___x-65-8-14
Average 90 stars, based on 1 article reviews
cd164 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
R&D Systems sheep anti human cd164 primary antibody
(A) Pedigree of a large Danish family with moderate hearing impairment, with the proband indicated with an arrow. DNA was available from all individuals except those with a four-digit ID. The presence (+) or absence (-) of the <t>CD164</t> mutation c.574C>T (p.R192*) is listed underneath each individual. The phenotype of individual (IV-21) was set to unknown (shown in grey) because of uncertainties about the origin of his hearing loss. (B) Audiograms of left and right ear of a representative affected family members (individual IV-5). Mid-frequencies are more severely affected than lower and higher frequencies termed basin shaped or cookie bite hearing loss. The age of the individual at the time of each analysis is indicated. (C) Genome-wide significant linkage to chromosome 6q15-21 was identified in an initial SNP-array analysis including 11 individuals (indicated in yellow, Fig 1A). (D) Chromatograms of the c.574C>T mutation in CD164 exon 6 in an affected family member compared to a healthy control individual. Nomenclature refers to RefSeq NM_006016.4 ( CD164 isoform 1), with nucleotide number +1 being A of the start codon ATG.
Sheep Anti Human Cd164 Primary Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd164/Human+CD164+Antibody/pmc04510537-269-19-34
Average 94 stars, based on 1 article reviews
sheep anti human cd164 primary antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

85
St Johns Laboratory anti cd164
(A) Pedigree of a large Danish family with moderate hearing impairment, with the proband indicated with an arrow. DNA was available from all individuals except those with a four-digit ID. The presence (+) or absence (-) of the <t>CD164</t> mutation c.574C>T (p.R192*) is listed underneath each individual. The phenotype of individual (IV-21) was set to unknown (shown in grey) because of uncertainties about the origin of his hearing loss. (B) Audiograms of left and right ear of a representative affected family members (individual IV-5). Mid-frequencies are more severely affected than lower and higher frequencies termed basin shaped or cookie bite hearing loss. The age of the individual at the time of each analysis is indicated. (C) Genome-wide significant linkage to chromosome 6q15-21 was identified in an initial SNP-array analysis including 11 individuals (indicated in yellow, Fig 1A). (D) Chromatograms of the c.574C>T mutation in CD164 exon 6 in an affected family member compared to a healthy control individual. Nomenclature refers to RefSeq NM_006016.4 ( CD164 isoform 1), with nucleotide number +1 being A of the start codon ATG.
Anti Cd164, supplied by St Johns Laboratory, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd164/Anti-CD164+Antibody/pmc04510537-292-5-10
Average 85 stars, based on 1 article reviews
anti cd164 - by Bioz Stars, 2026-11
85/100 stars
  Buy from Supplier

90
Boster Bio mouse anti human type iii collagen monoclonal antibody
(A) Pedigree of a large Danish family with moderate hearing impairment, with the proband indicated with an arrow. DNA was available from all individuals except those with a four-digit ID. The presence (+) or absence (-) of the <t>CD164</t> mutation c.574C>T (p.R192*) is listed underneath each individual. The phenotype of individual (IV-21) was set to unknown (shown in grey) because of uncertainties about the origin of his hearing loss. (B) Audiograms of left and right ear of a representative affected family members (individual IV-5). Mid-frequencies are more severely affected than lower and higher frequencies termed basin shaped or cookie bite hearing loss. The age of the individual at the time of each analysis is indicated. (C) Genome-wide significant linkage to chromosome 6q15-21 was identified in an initial SNP-array analysis including 11 individuals (indicated in yellow, Fig 1A). (D) Chromatograms of the c.574C>T mutation in CD164 exon 6 in an affected family member compared to a healthy control individual. Nomenclature refers to RefSeq NM_006016.4 ( CD164 isoform 1), with nucleotide number +1 being A of the start codon ATG.
Mouse Anti Human Type Iii Collagen Monoclonal Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd164/Anti-Hu+CD164+Purified+Monoclonal+Antibody/pmc06231324-23-5-29
Average 90 stars, based on 1 article reviews
mouse anti human type iii collagen monoclonal antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Becton Dickinson anti-cd164
The cell surface expression of <t>CD26,</t> CD164 and FCRL3 was assessed by flow cytometry. (a) SS patients (n=59) demonstrate significantly higher percentages of CD4+CD164+ and CD4+CD26− T cells compared to MF patients (n=10), or HD (n=14). (b) Percentage of CD4+CD164+ T cells is significantly higher in high (HT; n=37), medium (MT; n=14) and low (LT; n=8) tumor burden patients compared to MF, HD or AD patients (n=6). (c) Percentage of CD4+FCRL3+ T cells is significantly higher only in CD4 T cells of HT patients (n=26) but not in MT (n=15) or LT (n=7) compared to HD. Results are expressed as mean with 95% CL (d) CD164 and FCRL3 are predominately expressed on CD4+CD26− and CD4+CD26-Vβ+ T cells. Shown results are from one representative patient (out of seven) with a TCRVβ defined by antibody (upper panel) and from one representative patient (out of fourteen) whose TCRVβ was not defined by antibody (lower panel). Patients’ PBMC were collected prior to initiation of systemic therapy at the University of Pennsylvania.
Anti Cd164, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd164/anti+cd164+n6b6/pmc03869886-85-20-25
Average 90 stars, based on 1 article reviews
anti-cd164 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
honeywell international blue cd164
The cell surface expression of <t>CD26,</t> CD164 and FCRL3 was assessed by flow cytometry. (a) SS patients (n=59) demonstrate significantly higher percentages of CD4+CD164+ and CD4+CD26− T cells compared to MF patients (n=10), or HD (n=14). (b) Percentage of CD4+CD164+ T cells is significantly higher in high (HT; n=37), medium (MT; n=14) and low (LT; n=8) tumor burden patients compared to MF, HD or AD patients (n=6). (c) Percentage of CD4+FCRL3+ T cells is significantly higher only in CD4 T cells of HT patients (n=26) but not in MT (n=15) or LT (n=7) compared to HD. Results are expressed as mean with 95% CL (d) CD164 and FCRL3 are predominately expressed on CD4+CD26− and CD4+CD26-Vβ+ T cells. Shown results are from one representative patient (out of seven) with a TCRVβ defined by antibody (upper panel) and from one representative patient (out of fourteen) whose TCRVβ was not defined by antibody (lower panel). Patients’ PBMC were collected prior to initiation of systemic therapy at the University of Pennsylvania.
Blue Cd164, supplied by honeywell international, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd164/blue+cd164/us07927409-136-78-94
Average 90 stars, based on 1 article reviews
blue cd164 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Promega human cd164 cdna probes h1, h2, h3, and h4
The cell surface expression of <t>CD26,</t> CD164 and FCRL3 was assessed by flow cytometry. (a) SS patients (n=59) demonstrate significantly higher percentages of CD4+CD164+ and CD4+CD26− T cells compared to MF patients (n=10), or HD (n=14). (b) Percentage of CD4+CD164+ T cells is significantly higher in high (HT; n=37), medium (MT; n=14) and low (LT; n=8) tumor burden patients compared to MF, HD or AD patients (n=6). (c) Percentage of CD4+FCRL3+ T cells is significantly higher only in CD4 T cells of HT patients (n=26) but not in MT (n=15) or LT (n=7) compared to HD. Results are expressed as mean with 95% CL (d) CD164 and FCRL3 are predominately expressed on CD4+CD26− and CD4+CD26-Vβ+ T cells. Shown results are from one representative patient (out of seven) with a TCRVβ defined by antibody (upper panel) and from one representative patient (out of fourteen) whose TCRVβ was not defined by antibody (lower panel). Patients’ PBMC were collected prior to initiation of systemic therapy at the University of Pennsylvania.
Human Cd164 Cdna Probes H1, H2, H3, And H4, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd164/human+cd164+cdna+probes+h1++h2++h3++and+h4/10__1074_slash_jbc__m007965200-54-21-49
Average 90 stars, based on 1 article reviews
human cd164 cdna probes h1, h2, h3, and h4 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
GeneTex primary antibodies against cd164
<t>CD164</t> plays an important role in the apoptosis of spermatogonia. A) High‐frequency genes downregulated in spermatogonial stem cells (SSC) of four classes idiopathic nonobstructive azoospermia (iNOA). B) The expression levels of CD164 in human spermatogenesis. The two‐tailed Mann–Whitney–Wilcoxon test was used to assess significance. C) Immunostaining of CD164, LIN28A (a marker for undifferentiated spermatogonia), and SOHLH2 (a marker for differentiated spermatogonia) in testis sections from human adults. The DNA was stained with DAPI. Scale bar = 20 µm. Immunostaining of CD164, Lin28A (a marker for undifferentiated spermatogonia) and C‐Kit (a marker for differentiated spermatogonial) in testis sections from wild type mice at the indicated times. The DNA was stained with DAPI. Scale bar = 50 µm. D) Cd164 mRNA levels in GC1 cells infected with either two independent Cd164 siRNA or a scrambled siRNA (Ctrl siRNA). The results are normalized to the Gapdh mRNA level. n = 3, Error bars, S.D. * p < 0.05, ** p < 0.01 by two‐tailed Student's t test. E) GC1 cells stained with Annexin V‐FITC/PI were analyzed by flow cytometry, Q1: dead cells (FITC − /PI + ), Q2: late apoptosis (FITC + /PI + ), Q3: viable cells (FITC − /PI − ), Q4: early apoptosis (FITC + /PI − ). Histogram of the total apoptotic rate in different groups. The total apoptosis rate was defined as late apoptosis plus early apoptosis. n = 3, Error bars, S.D. * p < 0.05 by two‐tailed Student's t test. F) Gene expression patterns of molecules in the apoptosis signaling pathway and the possible mechanism by which CD164 promotes spermatogonia apoptosis. The two‐tailed Student's t test was used to assess significance.
Primary Antibodies Against Cd164, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd164/primary+antibodies+against+cd164/pmc10265083-240-39-44
Average 90 stars, based on 1 article reviews
primary antibodies against cd164 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


(A) Schematic of CRISPR-based KO screen done in A549 lung epithelial cells for the identification of LCMV host factors. (B) Gene enrichment for CRISPR screen of rLCMV-mCherry infection. Enrichment scores were determined by MaGECK analysis and genes were colored by biological function. Dotted line indicates −log10(Enrichment Score) = 4. All genes and their enrichment scores can be found in Table S1 . (C) Percentage of infected cells as determined by flow cytometry following infection of A549 homozygous knockouts (CD164, SPR14, IL2RA, KHNYN) or heterozygous knockouts (ARFRP1, YKT6, ACKR4, RAB10, EMC1, SYS1) with rLCMV-mCherry. Wildtype cells were used as normalization controls. Cells were infected at MOI 1 and harvested at 24 hpi. Error bars indicate standard error of three independent experiments. (D) Quantification of viral infection in WT, Δ CD164 , Δ CD164 complemented with human CD164 (Δ CD164 + hCD164 ), and Δ CD164 complemented with mouse Cd164 (Δ CD164 + mCd164 ) in A549, 293T, and 3T6 cell type backgrounds. Cells were infected with rLCMV-mCherry at MOI 1 and harvested at 24 hpi. Error bars indicate standard error of three independent experiments.

Journal: bioRxiv

Article Title: Human sialomucin CD164 is an essential entry factor for lymphocytic choriomeningitis virus

doi: 10.1101/2022.01.24.477570

Figure Lengend Snippet: (A) Schematic of CRISPR-based KO screen done in A549 lung epithelial cells for the identification of LCMV host factors. (B) Gene enrichment for CRISPR screen of rLCMV-mCherry infection. Enrichment scores were determined by MaGECK analysis and genes were colored by biological function. Dotted line indicates −log10(Enrichment Score) = 4. All genes and their enrichment scores can be found in Table S1 . (C) Percentage of infected cells as determined by flow cytometry following infection of A549 homozygous knockouts (CD164, SPR14, IL2RA, KHNYN) or heterozygous knockouts (ARFRP1, YKT6, ACKR4, RAB10, EMC1, SYS1) with rLCMV-mCherry. Wildtype cells were used as normalization controls. Cells were infected at MOI 1 and harvested at 24 hpi. Error bars indicate standard error of three independent experiments. (D) Quantification of viral infection in WT, Δ CD164 , Δ CD164 complemented with human CD164 (Δ CD164 + hCD164 ), and Δ CD164 complemented with mouse Cd164 (Δ CD164 + mCd164 ) in A549, 293T, and 3T6 cell type backgrounds. Cells were infected with rLCMV-mCherry at MOI 1 and harvested at 24 hpi. Error bars indicate standard error of three independent experiments.

Article Snippet: Human CD164 (Origene, #RC202234) and mouse Cd164 (Origene, #MR201951) cDNAs were cloned into EcoRV-cut plenti-CMV-Puro-DEST (Addgene #17452, gift from Eric Campeau & Paul Kaufman)( ) using NEBuilder HiFi DNA Assembly Master Mix (NEB).

Techniques: CRISPR, Infection, Flow Cytometry

(A) Log fold changes (LFC) of individual sgRNA of the top 10 scoring genes and CD164 (red) when comparing the infected and sorted cell population versus the uninfected cell population. Overall sgRNA distribution is shown at the bottom of the graph and dotted line indicates mean LFC of all sgRNAs. (B-D) Dose-response curve of v-ATPase inhibitors on rLCMV-mCherry infection at MOI 1 in A549 cells at 24 hpi, yielding (B) Bafilomycin A 1 IC50 = 2.96 nM, (C) Bafilomycin B 1 IC50 = 4.97 nM, and (D) Concanamycin A IC50 = 0.83 nM. Error bars indicate standard error of three independent experiments. (E) Genotyping of clonal A549 where the target loci were PCR-amplified, Sanger-sequenced, and aligned to WT reference sequence. (F) Analysis of cell proliferation of WT and clonal A549 KO cells. Cells were plated in 96-well and proliferation was measured daily using Cell Titer Glo. Error bars indicate standard error from three separate well per cell line per time point. (G-I) Western blot analysis of WT, Δ CD164 , Δ CD164 + hCD164 , and Δ CD164 + mCd164 for A549, 293T, and 3T6 cell lines. Human cell lines (A549 and 293T) were probed with anti-hCD164 antibody except for the mCd164 addback which was probed with anti-mCd164 antibody. Mouse cell line 3T6 was probed with anti-mCd164 antibody except for the hCD164 addback, which was probed with anti-hCD164 antibody. GAPDH was used as loading control.

Journal: bioRxiv

Article Title: Human sialomucin CD164 is an essential entry factor for lymphocytic choriomeningitis virus

doi: 10.1101/2022.01.24.477570

Figure Lengend Snippet: (A) Log fold changes (LFC) of individual sgRNA of the top 10 scoring genes and CD164 (red) when comparing the infected and sorted cell population versus the uninfected cell population. Overall sgRNA distribution is shown at the bottom of the graph and dotted line indicates mean LFC of all sgRNAs. (B-D) Dose-response curve of v-ATPase inhibitors on rLCMV-mCherry infection at MOI 1 in A549 cells at 24 hpi, yielding (B) Bafilomycin A 1 IC50 = 2.96 nM, (C) Bafilomycin B 1 IC50 = 4.97 nM, and (D) Concanamycin A IC50 = 0.83 nM. Error bars indicate standard error of three independent experiments. (E) Genotyping of clonal A549 where the target loci were PCR-amplified, Sanger-sequenced, and aligned to WT reference sequence. (F) Analysis of cell proliferation of WT and clonal A549 KO cells. Cells were plated in 96-well and proliferation was measured daily using Cell Titer Glo. Error bars indicate standard error from three separate well per cell line per time point. (G-I) Western blot analysis of WT, Δ CD164 , Δ CD164 + hCD164 , and Δ CD164 + mCd164 for A549, 293T, and 3T6 cell lines. Human cell lines (A549 and 293T) were probed with anti-hCD164 antibody except for the mCd164 addback which was probed with anti-mCd164 antibody. Mouse cell line 3T6 was probed with anti-mCd164 antibody except for the hCD164 addback, which was probed with anti-hCD164 antibody. GAPDH was used as loading control.

Article Snippet: Human CD164 (Origene, #RC202234) and mouse Cd164 (Origene, #MR201951) cDNAs were cloned into EcoRV-cut plenti-CMV-Puro-DEST (Addgene #17452, gift from Eric Campeau & Paul Kaufman)( ) using NEBuilder HiFi DNA Assembly Master Mix (NEB).

Techniques: Infection, Amplification, Sequencing, Western Blot, Control

(A-B) Western blot analysis of Δ CD164 , Δ DAG1 , and Δ CD164 /Δ DAG1 double KO cells in (A) A549 or (B) 293T cell backgrounds. GAPDH was used as a loading control.

Journal: bioRxiv

Article Title: Human sialomucin CD164 is an essential entry factor for lymphocytic choriomeningitis virus

doi: 10.1101/2022.01.24.477570

Figure Lengend Snippet: (A-B) Western blot analysis of Δ CD164 , Δ DAG1 , and Δ CD164 /Δ DAG1 double KO cells in (A) A549 or (B) 293T cell backgrounds. GAPDH was used as a loading control.

Article Snippet: Human CD164 (Origene, #RC202234) and mouse Cd164 (Origene, #MR201951) cDNAs were cloned into EcoRV-cut plenti-CMV-Puro-DEST (Addgene #17452, gift from Eric Campeau & Paul Kaufman)( ) using NEBuilder HiFi DNA Assembly Master Mix (NEB).

Techniques: Western Blot, Control

(A-E) Percent infection of Δ CD164 , Δ DAG1 , and Δ CD164 /Δ DAG1 double-KO cells relative to WT in either A549 or 293T cell type backgrounds following inoculation with low DAG1 affinity LCMV strains (A) Armstrong 53b-GP or (B) WE2.2-GP, and high DAG1 affinity strains (C) Armstrong Clone 13-GP, (D) W54-GP, or (E) WE-GP pseudotyped virus as determined by flow cytometry for GFP positivity. Cells were infected at MOI 1 and measured 24 hpi. Error bars indicate standard error of three independent experiments. (F-H) Percent infection of ΔCD164, ΔDAG1, and ΔCD164/ΔDAG1 double-KO cells relative to WT in either A549 or 293T cell type backgrounds following inoculation with (D) LASV-GP, (E) GTOV-GP, or (F) MACV-GP pseudotyped virus as determined by flow cytometry for GFP positivity. Cells were infected at MOI 1 and measured 24 hpi. Error bars indicate standard error of three independent experiments.

Journal: bioRxiv

Article Title: Human sialomucin CD164 is an essential entry factor for lymphocytic choriomeningitis virus

doi: 10.1101/2022.01.24.477570

Figure Lengend Snippet: (A-E) Percent infection of Δ CD164 , Δ DAG1 , and Δ CD164 /Δ DAG1 double-KO cells relative to WT in either A549 or 293T cell type backgrounds following inoculation with low DAG1 affinity LCMV strains (A) Armstrong 53b-GP or (B) WE2.2-GP, and high DAG1 affinity strains (C) Armstrong Clone 13-GP, (D) W54-GP, or (E) WE-GP pseudotyped virus as determined by flow cytometry for GFP positivity. Cells were infected at MOI 1 and measured 24 hpi. Error bars indicate standard error of three independent experiments. (F-H) Percent infection of ΔCD164, ΔDAG1, and ΔCD164/ΔDAG1 double-KO cells relative to WT in either A549 or 293T cell type backgrounds following inoculation with (D) LASV-GP, (E) GTOV-GP, or (F) MACV-GP pseudotyped virus as determined by flow cytometry for GFP positivity. Cells were infected at MOI 1 and measured 24 hpi. Error bars indicate standard error of three independent experiments.

Article Snippet: Human CD164 (Origene, #RC202234) and mouse Cd164 (Origene, #MR201951) cDNAs were cloned into EcoRV-cut plenti-CMV-Puro-DEST (Addgene #17452, gift from Eric Campeau & Paul Kaufman)( ) using NEBuilder HiFi DNA Assembly Master Mix (NEB).

Techniques: Infection, Virus, Flow Cytometry

(A) Schematic (left) of wildtype, Δ CD164 , Δ CD164 + hCD164 (ΔE1), Δ CD164 + hCD164 (ΔE1-2), Δ CD164 + hCD164 (ΔE1-3), Δ CD164 + hCD164 (ΔE1-4), Δ CD164 + hCD164 (ΔE1-5), and Δ CD164 + hCD164 (ΔE2-6). Complemented A549 and 293T cells were challenged with rLCMV-mCherry (MOI 1) and infection was measured by flow cytometry at 24 hpi (right). Percent infection was normalized to wildtype. Error bars represent standard error of three independent experiments. (B) Schematic (left) of wildtype, ΔCD164 KO + hCD164(N72A), ΔCD164 + hCD164(N77A), ΔCD164 + hCD164(N94A), and ΔCD164 + hCD164(N104A). Complemented A549 and 293T cells were challenged with rLCMV-mCherry (MOI 1) and infection was measured by flow cytometry at 24 hpi (right). Percent infection was normalized to wildtype. Error bars represent standard error of three independent experiments. (C) Amino acid similarities of the cysteine-rich region in human CD164 and mouse Cd164 determined using the ClustalW program on SnapGene. Yellow circles indicate cysteine residues, red N symbolizes N-linked glycosylation sites, and identical amino acids are highlighted in green. (D) Blockade of LCMV infection with serial dilutions of anti-human CD164 monoclonal mouse antibody clone N6B6 or mouse IgG2a-κ isotope control in wild type A549 cells. Cells were infected at MOI 1 and infection measured at 24 hpi. Error bars indicate standard error of three independent experiments.

Journal: bioRxiv

Article Title: Human sialomucin CD164 is an essential entry factor for lymphocytic choriomeningitis virus

doi: 10.1101/2022.01.24.477570

Figure Lengend Snippet: (A) Schematic (left) of wildtype, Δ CD164 , Δ CD164 + hCD164 (ΔE1), Δ CD164 + hCD164 (ΔE1-2), Δ CD164 + hCD164 (ΔE1-3), Δ CD164 + hCD164 (ΔE1-4), Δ CD164 + hCD164 (ΔE1-5), and Δ CD164 + hCD164 (ΔE2-6). Complemented A549 and 293T cells were challenged with rLCMV-mCherry (MOI 1) and infection was measured by flow cytometry at 24 hpi (right). Percent infection was normalized to wildtype. Error bars represent standard error of three independent experiments. (B) Schematic (left) of wildtype, ΔCD164 KO + hCD164(N72A), ΔCD164 + hCD164(N77A), ΔCD164 + hCD164(N94A), and ΔCD164 + hCD164(N104A). Complemented A549 and 293T cells were challenged with rLCMV-mCherry (MOI 1) and infection was measured by flow cytometry at 24 hpi (right). Percent infection was normalized to wildtype. Error bars represent standard error of three independent experiments. (C) Amino acid similarities of the cysteine-rich region in human CD164 and mouse Cd164 determined using the ClustalW program on SnapGene. Yellow circles indicate cysteine residues, red N symbolizes N-linked glycosylation sites, and identical amino acids are highlighted in green. (D) Blockade of LCMV infection with serial dilutions of anti-human CD164 monoclonal mouse antibody clone N6B6 or mouse IgG2a-κ isotope control in wild type A549 cells. Cells were infected at MOI 1 and infection measured at 24 hpi. Error bars indicate standard error of three independent experiments.

Article Snippet: Human CD164 (Origene, #RC202234) and mouse Cd164 (Origene, #MR201951) cDNAs were cloned into EcoRV-cut plenti-CMV-Puro-DEST (Addgene #17452, gift from Eric Campeau & Paul Kaufman)( ) using NEBuilder HiFi DNA Assembly Master Mix (NEB).

Techniques: Infection, Flow Cytometry, Glycoproteomics, Control

(A-B) Western blot analysis of deletion domain addbacks in (A) A549 or (B) 293T cell backgrounds. (C-D) Western blot analysis of alanine mutagenesis addbacks in (C) A549 or (D) 293T cell backgrounds. All CD164 addbacks were probed with anti-FLAG antibody. GAPDH was used as a loading control. (E) AlphaFold prediction of CD164 protein structure. Prediction had low position error for the signal peptide, the cysteine-rich region, the transmembrane domain, and the cytoplasmic tail and high position error for the two mucin domains. Location of residue 104 is noted with an arrow.

Journal: bioRxiv

Article Title: Human sialomucin CD164 is an essential entry factor for lymphocytic choriomeningitis virus

doi: 10.1101/2022.01.24.477570

Figure Lengend Snippet: (A-B) Western blot analysis of deletion domain addbacks in (A) A549 or (B) 293T cell backgrounds. (C-D) Western blot analysis of alanine mutagenesis addbacks in (C) A549 or (D) 293T cell backgrounds. All CD164 addbacks were probed with anti-FLAG antibody. GAPDH was used as a loading control. (E) AlphaFold prediction of CD164 protein structure. Prediction had low position error for the signal peptide, the cysteine-rich region, the transmembrane domain, and the cytoplasmic tail and high position error for the two mucin domains. Location of residue 104 is noted with an arrow.

Article Snippet: Human CD164 (Origene, #RC202234) and mouse Cd164 (Origene, #MR201951) cDNAs were cloned into EcoRV-cut plenti-CMV-Puro-DEST (Addgene #17452, gift from Eric Campeau & Paul Kaufman)( ) using NEBuilder HiFi DNA Assembly Master Mix (NEB).

Techniques: Western Blot, Mutagenesis, Control, Residue

(A) Double immunofluorescence staining for CD164 and CK7 or isotypes staining followed by counterstaining with DAPI in villous trophoblastic tissue. Original images were taken by confocal microscopy at 100x magnification. Scale bar represents 20 μm. (B) Immunofluorescence imaging of JEG-3 placenta cells pre-incubated with various concentrations of anti-CD164 mAb N6B6 and infected with r3LCMV-mCherry at MOI 0.5. Cells were fixed and imaged at 10x magnification 24 hpi. Scale bar represents 20 μm. (C) Quantification of percent infection of JEG-3 placenta cells pre-incubated with various concentrations of anti-CD164 mAb N6B6 and infected with r3LCMV-mCherry at MOI 0.5. Analysis was done on 4 FOV in 2 independent infections and normalized to infection control.

Journal: bioRxiv

Article Title: Human sialomucin CD164 is an essential entry factor for lymphocytic choriomeningitis virus

doi: 10.1101/2022.01.24.477570

Figure Lengend Snippet: (A) Double immunofluorescence staining for CD164 and CK7 or isotypes staining followed by counterstaining with DAPI in villous trophoblastic tissue. Original images were taken by confocal microscopy at 100x magnification. Scale bar represents 20 μm. (B) Immunofluorescence imaging of JEG-3 placenta cells pre-incubated with various concentrations of anti-CD164 mAb N6B6 and infected with r3LCMV-mCherry at MOI 0.5. Cells were fixed and imaged at 10x magnification 24 hpi. Scale bar represents 20 μm. (C) Quantification of percent infection of JEG-3 placenta cells pre-incubated with various concentrations of anti-CD164 mAb N6B6 and infected with r3LCMV-mCherry at MOI 0.5. Analysis was done on 4 FOV in 2 independent infections and normalized to infection control.

Article Snippet: Human CD164 (Origene, #RC202234) and mouse Cd164 (Origene, #MR201951) cDNAs were cloned into EcoRV-cut plenti-CMV-Puro-DEST (Addgene #17452, gift from Eric Campeau & Paul Kaufman)( ) using NEBuilder HiFi DNA Assembly Master Mix (NEB).

Techniques: Double Immunofluorescence Staining, Staining, Confocal Microscopy, Immunofluorescence, Imaging, Incubation, Infection, Control

(A) Immunofluorescence staining of CD164 or isotype control followed by counterstaining with DAPI on placenta tissue at the maternal decidua and fetal villi. Original images taken at 40x magnification. Scale bar represents 50 μm. (B) Immunofluorescence imaging of CD164 or isotype control followed by counterstaining with DAPI on JEG-3 placenta cell line. Original images taken at 10x magnification. Scale bar represents 100 μm. (C) Immunofluorescence imaging JEG-3 placenta cell line with and without infection by r3LCMV-mCherry at MOI 1 and imaged at 24 hpi. Original images taken at 10x magnification. Scale bar represents 100 μm.

Journal: bioRxiv

Article Title: Human sialomucin CD164 is an essential entry factor for lymphocytic choriomeningitis virus

doi: 10.1101/2022.01.24.477570

Figure Lengend Snippet: (A) Immunofluorescence staining of CD164 or isotype control followed by counterstaining with DAPI on placenta tissue at the maternal decidua and fetal villi. Original images taken at 40x magnification. Scale bar represents 50 μm. (B) Immunofluorescence imaging of CD164 or isotype control followed by counterstaining with DAPI on JEG-3 placenta cell line. Original images taken at 10x magnification. Scale bar represents 100 μm. (C) Immunofluorescence imaging JEG-3 placenta cell line with and without infection by r3LCMV-mCherry at MOI 1 and imaged at 24 hpi. Original images taken at 10x magnification. Scale bar represents 100 μm.

Article Snippet: Human CD164 (Origene, #RC202234) and mouse Cd164 (Origene, #MR201951) cDNAs were cloned into EcoRV-cut plenti-CMV-Puro-DEST (Addgene #17452, gift from Eric Campeau & Paul Kaufman)( ) using NEBuilder HiFi DNA Assembly Master Mix (NEB).

Techniques: Immunofluorescence, Staining, Control, Imaging, Infection

Fig. 5 ZON represses CD164 by enhancing miR-506-3p. A Expression of miR-506-3p was measured by qPCR in cervical cancer cells treated with ZON. B Wild type and mutant binding sites of CD164 with miR-506-3p. C, D Cervical cancer cells were treated with miR-506-3p mimic. C Luciferase activity of CD164 was detected by dual luciferase reporter gene assays. D Expression of CD164 was analyzed by qPCR. E Expression of CD164 was determined by Western blot in the cervical cancer cells. The experiments were repeated 3 times, **P < 0.01

Journal: Cancer Nanotechnology

Article Title: Zinc oxide nanoparticle regulates the ferroptosis, proliferation, invasion and steaminess of cervical cancer by miR-506-3p/CD164 signaling

doi: 10.1186/s12645-022-00134-x

Figure Lengend Snippet: Fig. 5 ZON represses CD164 by enhancing miR-506-3p. A Expression of miR-506-3p was measured by qPCR in cervical cancer cells treated with ZON. B Wild type and mutant binding sites of CD164 with miR-506-3p. C, D Cervical cancer cells were treated with miR-506-3p mimic. C Luciferase activity of CD164 was detected by dual luciferase reporter gene assays. D Expression of CD164 was analyzed by qPCR. E Expression of CD164 was determined by Western blot in the cervical cancer cells. The experiments were repeated 3 times, **P < 0.01

Article Snippet: Antibodies for ABCG2, C-Myc, Bmi1, Sox2, Vimentin, E-cadherin, CD164, and β-Catenin were purchased from Proteintech (China).

Techniques: Expressing, Mutagenesis, Binding Assay, Luciferase, Activity Assay, Western Blot

Fig. 6 CD164 reverses miR-506-3p-mediated stemness and ferroptosis of cervical cancer cells. A, B Cervical cancer cells were treated with miR-506-3p mimic or co-treated with CD164 overexpressing vectors. The sphere formation efficiency was detected by sphere formation assays. C–J RSL3 (1 μM)-stimulated cervical cancer cells were treated with miR-506-3p inhibitor or co-treated with miR-506-3p inhibitor and CD164 shRNA. The levels of GSH (C, D), MDA (E, F), lipid ROS (G, H), and iron (I, J) were analyzed. The experiments were repeated 3 times, **P < 0.01

Journal: Cancer Nanotechnology

Article Title: Zinc oxide nanoparticle regulates the ferroptosis, proliferation, invasion and steaminess of cervical cancer by miR-506-3p/CD164 signaling

doi: 10.1186/s12645-022-00134-x

Figure Lengend Snippet: Fig. 6 CD164 reverses miR-506-3p-mediated stemness and ferroptosis of cervical cancer cells. A, B Cervical cancer cells were treated with miR-506-3p mimic or co-treated with CD164 overexpressing vectors. The sphere formation efficiency was detected by sphere formation assays. C–J RSL3 (1 μM)-stimulated cervical cancer cells were treated with miR-506-3p inhibitor or co-treated with miR-506-3p inhibitor and CD164 shRNA. The levels of GSH (C, D), MDA (E, F), lipid ROS (G, H), and iron (I, J) were analyzed. The experiments were repeated 3 times, **P < 0.01

Article Snippet: Antibodies for ABCG2, C-Myc, Bmi1, Sox2, Vimentin, E-cadherin, CD164, and β-Catenin were purchased from Proteintech (China).

Techniques: shRNA

Fig. 8 ZON inhibits cell growth of cervical cancer in vivo by targeting CD164. A–D Tumor growth of C33A cell was analyzed by xenograft mouse model in vivo (n = 5). The tumor images (A), tumor weight (B), Ki-67 levels (C), and CD164 expression (D) were shown. The experiments were repeated 3 times, **P < 0.01

Journal: Cancer Nanotechnology

Article Title: Zinc oxide nanoparticle regulates the ferroptosis, proliferation, invasion and steaminess of cervical cancer by miR-506-3p/CD164 signaling

doi: 10.1186/s12645-022-00134-x

Figure Lengend Snippet: Fig. 8 ZON inhibits cell growth of cervical cancer in vivo by targeting CD164. A–D Tumor growth of C33A cell was analyzed by xenograft mouse model in vivo (n = 5). The tumor images (A), tumor weight (B), Ki-67 levels (C), and CD164 expression (D) were shown. The experiments were repeated 3 times, **P < 0.01

Article Snippet: Antibodies for ABCG2, C-Myc, Bmi1, Sox2, Vimentin, E-cadherin, CD164, and β-Catenin were purchased from Proteintech (China).

Techniques: In Vivo, Expressing

Fig. 7 ZON represses stemness and reduces ferroptosis of cervical cancer cells by targeting CD164. A, B Sphere formation efficiency was detected by sphere formation assays. C–J Levels of GSH (C, D), MDA (E, F), lipid ROS (G, H), and iron (I, J) were analyzed. The experiments were repeated 3 times, **P < 0.01

Journal: Cancer Nanotechnology

Article Title: Zinc oxide nanoparticle regulates the ferroptosis, proliferation, invasion and steaminess of cervical cancer by miR-506-3p/CD164 signaling

doi: 10.1186/s12645-022-00134-x

Figure Lengend Snippet: Fig. 7 ZON represses stemness and reduces ferroptosis of cervical cancer cells by targeting CD164. A, B Sphere formation efficiency was detected by sphere formation assays. C–J Levels of GSH (C, D), MDA (E, F), lipid ROS (G, H), and iron (I, J) were analyzed. The experiments were repeated 3 times, **P < 0.01

Article Snippet: Antibodies for ABCG2, C-Myc, Bmi1, Sox2, Vimentin, E-cadherin, CD164, and β-Catenin were purchased from Proteintech (China).

Techniques:

(A) Pedigree of a large Danish family with moderate hearing impairment, with the proband indicated with an arrow. DNA was available from all individuals except those with a four-digit ID. The presence (+) or absence (-) of the CD164 mutation c.574C>T (p.R192*) is listed underneath each individual. The phenotype of individual (IV-21) was set to unknown (shown in grey) because of uncertainties about the origin of his hearing loss. (B) Audiograms of left and right ear of a representative affected family members (individual IV-5). Mid-frequencies are more severely affected than lower and higher frequencies termed basin shaped or cookie bite hearing loss. The age of the individual at the time of each analysis is indicated. (C) Genome-wide significant linkage to chromosome 6q15-21 was identified in an initial SNP-array analysis including 11 individuals (indicated in yellow, Fig 1A). (D) Chromatograms of the c.574C>T mutation in CD164 exon 6 in an affected family member compared to a healthy control individual. Nomenclature refers to RefSeq NM_006016.4 ( CD164 isoform 1), with nucleotide number +1 being A of the start codon ATG.

Journal: PLoS Genetics

Article Title: A Novel Locus Harbouring a Functional CD164 Nonsense Mutation Identified in a Large Danish Family with Nonsyndromic Hearing Impairment

doi: 10.1371/journal.pgen.1005386

Figure Lengend Snippet: (A) Pedigree of a large Danish family with moderate hearing impairment, with the proband indicated with an arrow. DNA was available from all individuals except those with a four-digit ID. The presence (+) or absence (-) of the CD164 mutation c.574C>T (p.R192*) is listed underneath each individual. The phenotype of individual (IV-21) was set to unknown (shown in grey) because of uncertainties about the origin of his hearing loss. (B) Audiograms of left and right ear of a representative affected family members (individual IV-5). Mid-frequencies are more severely affected than lower and higher frequencies termed basin shaped or cookie bite hearing loss. The age of the individual at the time of each analysis is indicated. (C) Genome-wide significant linkage to chromosome 6q15-21 was identified in an initial SNP-array analysis including 11 individuals (indicated in yellow, Fig 1A). (D) Chromatograms of the c.574C>T mutation in CD164 exon 6 in an affected family member compared to a healthy control individual. Nomenclature refers to RefSeq NM_006016.4 ( CD164 isoform 1), with nucleotide number +1 being A of the start codon ATG.

Article Snippet: For CD164 protein expression analysis, cells were thereafter lysed in reducing SDS-PAGE sample buffer and subjected to immunoblotting using sheep anti-human CD164 primary antibody (AF5790) and horseradish peroxidase-coupled anti-sheep secondary antibody (HAF016), both from R&D Systems.

Techniques: Mutagenesis, Genome Wide, Control

(A) The nonsense mutation was identified in exon 6, used by the three membrane bound isoforms of CD164. (B) A schematic representation of CD164 isoform 1. The protein contains two mucin-like domains separated by a cysteine-rich domain . The locations of potential N-glycosylations sites and predicted O-glycosylation sites were predicted from the NetOGlyc 4.0 Server ( http://www.cbs.dtu.dk/services/NetOGlyc/ ). The location of the transmembrane region was predicted from the SMART database (smart.embl-heidelberg.de). (C) Alignment of the amino acid sequence of CD164 different species shows high evolutionary conservation of the C-terminal region including the YHTL sorting motif, which is deleted as a consequence of the nonsense mutation. Isoform 4 and 1 are the most predominantly expressed isoforms across a broad range of tissues. Information on isoforms was accessed from the GTEx Portal ( http://www.gtexportal.org/home/ ).

Journal: PLoS Genetics

Article Title: A Novel Locus Harbouring a Functional CD164 Nonsense Mutation Identified in a Large Danish Family with Nonsyndromic Hearing Impairment

doi: 10.1371/journal.pgen.1005386

Figure Lengend Snippet: (A) The nonsense mutation was identified in exon 6, used by the three membrane bound isoforms of CD164. (B) A schematic representation of CD164 isoform 1. The protein contains two mucin-like domains separated by a cysteine-rich domain . The locations of potential N-glycosylations sites and predicted O-glycosylation sites were predicted from the NetOGlyc 4.0 Server ( http://www.cbs.dtu.dk/services/NetOGlyc/ ). The location of the transmembrane region was predicted from the SMART database (smart.embl-heidelberg.de). (C) Alignment of the amino acid sequence of CD164 different species shows high evolutionary conservation of the C-terminal region including the YHTL sorting motif, which is deleted as a consequence of the nonsense mutation. Isoform 4 and 1 are the most predominantly expressed isoforms across a broad range of tissues. Information on isoforms was accessed from the GTEx Portal ( http://www.gtexportal.org/home/ ).

Article Snippet: For CD164 protein expression analysis, cells were thereafter lysed in reducing SDS-PAGE sample buffer and subjected to immunoblotting using sheep anti-human CD164 primary antibody (AF5790) and horseradish peroxidase-coupled anti-sheep secondary antibody (HAF016), both from R&D Systems.

Techniques: Mutagenesis, Membrane, Glycoproteomics, Sequencing

HEK-293 cells were co-transfected with plasmid expressing mCherry fused to the C-terminal region (CTR) of wild-type CD164 and eGFP fused to the CTR of CD164-R192* or vice versa . Forty-eight hours post-transfection, live imaging of the cells was performed using a confocal laser scanning microscope using 63×water-immersion objective. (A) Schematic of the constructs (B) Wild-type fusion protein (mCherry-CD164-WT-CTR) (red) was intracellularly located while the truncated fusion protein (eGFP-CD164-R192*-CTR) was primarily present at the plasma membrane. (C) Same result was found when reversing mCherry and eGFP (colour swap).

Journal: PLoS Genetics

Article Title: A Novel Locus Harbouring a Functional CD164 Nonsense Mutation Identified in a Large Danish Family with Nonsyndromic Hearing Impairment

doi: 10.1371/journal.pgen.1005386

Figure Lengend Snippet: HEK-293 cells were co-transfected with plasmid expressing mCherry fused to the C-terminal region (CTR) of wild-type CD164 and eGFP fused to the CTR of CD164-R192* or vice versa . Forty-eight hours post-transfection, live imaging of the cells was performed using a confocal laser scanning microscope using 63×water-immersion objective. (A) Schematic of the constructs (B) Wild-type fusion protein (mCherry-CD164-WT-CTR) (red) was intracellularly located while the truncated fusion protein (eGFP-CD164-R192*-CTR) was primarily present at the plasma membrane. (C) Same result was found when reversing mCherry and eGFP (colour swap).

Article Snippet: For CD164 protein expression analysis, cells were thereafter lysed in reducing SDS-PAGE sample buffer and subjected to immunoblotting using sheep anti-human CD164 primary antibody (AF5790) and horseradish peroxidase-coupled anti-sheep secondary antibody (HAF016), both from R&D Systems.

Techniques: Transfection, Plasmid Preparation, Expressing, Imaging, Laser-Scanning Microscopy, Construct, Clinical Proteomics, Membrane

HEK cells stably overexpressing wild-type CD164 (CD164 WT) (A, C, E), and truncated CD164 (CD164 R192*) (B, D, F) were seeded on cover slides and were incubated with anti-CD164 antibody on ice. Next, cells were either fixed (T0, 0 min) or incubated at 37°C in complete medium without antibody for 10 (T10) and 30 (T30) minutes, respectively, and then fixed. Finally, CD164 was visualized using Alexa Fluor 488-labeled secondary antibody (green). Nuclear DNA was stained with DAPI (blue). Imaging was performed on a confocal laser scanning microscope using 40×oil-immersion objective. Scale bar = 6 μm.

Journal: PLoS Genetics

Article Title: A Novel Locus Harbouring a Functional CD164 Nonsense Mutation Identified in a Large Danish Family with Nonsyndromic Hearing Impairment

doi: 10.1371/journal.pgen.1005386

Figure Lengend Snippet: HEK cells stably overexpressing wild-type CD164 (CD164 WT) (A, C, E), and truncated CD164 (CD164 R192*) (B, D, F) were seeded on cover slides and were incubated with anti-CD164 antibody on ice. Next, cells were either fixed (T0, 0 min) or incubated at 37°C in complete medium without antibody for 10 (T10) and 30 (T30) minutes, respectively, and then fixed. Finally, CD164 was visualized using Alexa Fluor 488-labeled secondary antibody (green). Nuclear DNA was stained with DAPI (blue). Imaging was performed on a confocal laser scanning microscope using 40×oil-immersion objective. Scale bar = 6 μm.

Article Snippet: For CD164 protein expression analysis, cells were thereafter lysed in reducing SDS-PAGE sample buffer and subjected to immunoblotting using sheep anti-human CD164 primary antibody (AF5790) and horseradish peroxidase-coupled anti-sheep secondary antibody (HAF016), both from R&D Systems.

Techniques: Stable Transfection, Incubation, Labeling, Staining, Imaging, Laser-Scanning Microscopy

HEK-293 cells were transiently transfected with empty vector, CD164 and CD164 R192*, either untagged or harboring various epitope tags and in various combinations. After 2 days, the cells were (A) lysed in SDS-PAGE sample buffer and analysed by immunoblotting using anti-human CD164 antibody or (B) lysed in immunoprecipitation buffer, whereafter CD164 or CD164 R192* were immunoprecipitated from the cell lysates using anti-HA antibody indicated. Aliquots of the immunoprecipitates or the pre-immunoprecipitation lysates were analysed by immunoblotting using the antibody indicated. SDS-PAGE was performed under reducing conditions. The asterisks indicate a non-specific band.

Journal: PLoS Genetics

Article Title: A Novel Locus Harbouring a Functional CD164 Nonsense Mutation Identified in a Large Danish Family with Nonsyndromic Hearing Impairment

doi: 10.1371/journal.pgen.1005386

Figure Lengend Snippet: HEK-293 cells were transiently transfected with empty vector, CD164 and CD164 R192*, either untagged or harboring various epitope tags and in various combinations. After 2 days, the cells were (A) lysed in SDS-PAGE sample buffer and analysed by immunoblotting using anti-human CD164 antibody or (B) lysed in immunoprecipitation buffer, whereafter CD164 or CD164 R192* were immunoprecipitated from the cell lysates using anti-HA antibody indicated. Aliquots of the immunoprecipitates or the pre-immunoprecipitation lysates were analysed by immunoblotting using the antibody indicated. SDS-PAGE was performed under reducing conditions. The asterisks indicate a non-specific band.

Article Snippet: For CD164 protein expression analysis, cells were thereafter lysed in reducing SDS-PAGE sample buffer and subjected to immunoblotting using sheep anti-human CD164 primary antibody (AF5790) and horseradish peroxidase-coupled anti-sheep secondary antibody (HAF016), both from R&D Systems.

Techniques: Transfection, Plasmid Preparation, SDS Page, Western Blot, Immunoprecipitation

Co-transfected HEK cells expressing wild-type CD164 tagged with the FLAG epitope (FLAG-CD164-WT) and truncated endolyn tagged with the HA epitope (HA-CD164-R192*) were seeded on cover slides. Following incubation with anti-FLAG and anti-HA antibodies on ice, the cells were either fixed (T0, 0 min) or incubated in complete medium without antibody for 10 (T10) and 30 (T30) minutes, respectively, and then fixed. FLAG-CD164-WT (A, D, G) and HA-CD164-R192* (B, E, H) was visualized using Alexa Fluor 488-labeled secondary antibody (green) and Alexa Fluor 568-labeled secondary antibody (red), respectively. Nuclear DNA was stained with DAPI (blue). Merged images are shown in (C, F, I). Imaging was performed on a confocal laser scanning microscope using 40×oil-immersion objective. Scale bar = 6 μm.

Journal: PLoS Genetics

Article Title: A Novel Locus Harbouring a Functional CD164 Nonsense Mutation Identified in a Large Danish Family with Nonsyndromic Hearing Impairment

doi: 10.1371/journal.pgen.1005386

Figure Lengend Snippet: Co-transfected HEK cells expressing wild-type CD164 tagged with the FLAG epitope (FLAG-CD164-WT) and truncated endolyn tagged with the HA epitope (HA-CD164-R192*) were seeded on cover slides. Following incubation with anti-FLAG and anti-HA antibodies on ice, the cells were either fixed (T0, 0 min) or incubated in complete medium without antibody for 10 (T10) and 30 (T30) minutes, respectively, and then fixed. FLAG-CD164-WT (A, D, G) and HA-CD164-R192* (B, E, H) was visualized using Alexa Fluor 488-labeled secondary antibody (green) and Alexa Fluor 568-labeled secondary antibody (red), respectively. Nuclear DNA was stained with DAPI (blue). Merged images are shown in (C, F, I). Imaging was performed on a confocal laser scanning microscope using 40×oil-immersion objective. Scale bar = 6 μm.

Article Snippet: For CD164 protein expression analysis, cells were thereafter lysed in reducing SDS-PAGE sample buffer and subjected to immunoblotting using sheep anti-human CD164 primary antibody (AF5790) and horseradish peroxidase-coupled anti-sheep secondary antibody (HAF016), both from R&D Systems.

Techniques: Transfection, Expressing, FLAG-tag, Incubation, Labeling, Staining, Imaging, Laser-Scanning Microscopy

(A) BLAT alignment of the sequenced cDNA (labeled “CD164 transcript” in the “your sequence from Blat search” track) from peripheral blood from a patient. The transcript does not contain intronic sequence indicating that the sequence is from mRNA. (B) Chromatogram of the c.574C>T mutation showed equal expression of both alleles in peripheral blood cells, demonstrating that the nonsense mutation is not degraded through NMD

Journal: PLoS Genetics

Article Title: A Novel Locus Harbouring a Functional CD164 Nonsense Mutation Identified in a Large Danish Family with Nonsyndromic Hearing Impairment

doi: 10.1371/journal.pgen.1005386

Figure Lengend Snippet: (A) BLAT alignment of the sequenced cDNA (labeled “CD164 transcript” in the “your sequence from Blat search” track) from peripheral blood from a patient. The transcript does not contain intronic sequence indicating that the sequence is from mRNA. (B) Chromatogram of the c.574C>T mutation showed equal expression of both alleles in peripheral blood cells, demonstrating that the nonsense mutation is not degraded through NMD

Article Snippet: For CD164 protein expression analysis, cells were thereafter lysed in reducing SDS-PAGE sample buffer and subjected to immunoblotting using sheep anti-human CD164 primary antibody (AF5790) and horseradish peroxidase-coupled anti-sheep secondary antibody (HAF016), both from R&D Systems.

Techniques: Labeling, Sequencing, Mutagenesis, Expressing

Immunohistochemistry shows cd164 expression (brown) in the cochlear neurons (arrows in A and C), inner hair cells (ihc) and outer hair cells (ohc) of the organ of Corti (black arrowheads in C), cells of Kolliker’s organ (red arrowhead in C), cells of the lateral wall behind the spiral prominence (open arrowhead in A) and in the stria vascularis (B). Scale bars: A: 10 μm, B, C: 5 μm.

Journal: PLoS Genetics

Article Title: A Novel Locus Harbouring a Functional CD164 Nonsense Mutation Identified in a Large Danish Family with Nonsyndromic Hearing Impairment

doi: 10.1371/journal.pgen.1005386

Figure Lengend Snippet: Immunohistochemistry shows cd164 expression (brown) in the cochlear neurons (arrows in A and C), inner hair cells (ihc) and outer hair cells (ohc) of the organ of Corti (black arrowheads in C), cells of Kolliker’s organ (red arrowhead in C), cells of the lateral wall behind the spiral prominence (open arrowhead in A) and in the stria vascularis (B). Scale bars: A: 10 μm, B, C: 5 μm.

Article Snippet: For CD164 protein expression analysis, cells were thereafter lysed in reducing SDS-PAGE sample buffer and subjected to immunoblotting using sheep anti-human CD164 primary antibody (AF5790) and horseradish peroxidase-coupled anti-sheep secondary antibody (HAF016), both from R&D Systems.

Techniques: Immunohistochemistry, Expressing

The cell surface expression of CD26, CD164 and FCRL3 was assessed by flow cytometry. (a) SS patients (n=59) demonstrate significantly higher percentages of CD4+CD164+ and CD4+CD26− T cells compared to MF patients (n=10), or HD (n=14). (b) Percentage of CD4+CD164+ T cells is significantly higher in high (HT; n=37), medium (MT; n=14) and low (LT; n=8) tumor burden patients compared to MF, HD or AD patients (n=6). (c) Percentage of CD4+FCRL3+ T cells is significantly higher only in CD4 T cells of HT patients (n=26) but not in MT (n=15) or LT (n=7) compared to HD. Results are expressed as mean with 95% CL (d) CD164 and FCRL3 are predominately expressed on CD4+CD26− and CD4+CD26-Vβ+ T cells. Shown results are from one representative patient (out of seven) with a TCRVβ defined by antibody (upper panel) and from one representative patient (out of fourteen) whose TCRVβ was not defined by antibody (lower panel). Patients’ PBMC were collected prior to initiation of systemic therapy at the University of Pennsylvania.

Journal: The Journal of investigative dermatology

Article Title: CD164 and FCRL3 are highly expressed on CD4+CD26-T cells in Sézary syndrome patients

doi: 10.1038/jid.2013.279

Figure Lengend Snippet: The cell surface expression of CD26, CD164 and FCRL3 was assessed by flow cytometry. (a) SS patients (n=59) demonstrate significantly higher percentages of CD4+CD164+ and CD4+CD26− T cells compared to MF patients (n=10), or HD (n=14). (b) Percentage of CD4+CD164+ T cells is significantly higher in high (HT; n=37), medium (MT; n=14) and low (LT; n=8) tumor burden patients compared to MF, HD or AD patients (n=6). (c) Percentage of CD4+FCRL3+ T cells is significantly higher only in CD4 T cells of HT patients (n=26) but not in MT (n=15) or LT (n=7) compared to HD. Results are expressed as mean with 95% CL (d) CD164 and FCRL3 are predominately expressed on CD4+CD26− and CD4+CD26-Vβ+ T cells. Shown results are from one representative patient (out of seven) with a TCRVβ defined by antibody (upper panel) and from one representative patient (out of fourteen) whose TCRVβ was not defined by antibody (lower panel). Patients’ PBMC were collected prior to initiation of systemic therapy at the University of Pennsylvania.

Article Snippet: To analyze the phenotype of CD4 T cells from patients and healthy donors, PBMCs were stained with antibodies anti-CD3, anti-CD4, anti-CD26, anti-CD164, anti-CD25 purchased from BD Biosciences, San Jose, CA and anti-FCRL3.

Techniques: Expressing, Flow Cytometry

CD164 plays an important role in the apoptosis of spermatogonia. A) High‐frequency genes downregulated in spermatogonial stem cells (SSC) of four classes idiopathic nonobstructive azoospermia (iNOA). B) The expression levels of CD164 in human spermatogenesis. The two‐tailed Mann–Whitney–Wilcoxon test was used to assess significance. C) Immunostaining of CD164, LIN28A (a marker for undifferentiated spermatogonia), and SOHLH2 (a marker for differentiated spermatogonia) in testis sections from human adults. The DNA was stained with DAPI. Scale bar = 20 µm. Immunostaining of CD164, Lin28A (a marker for undifferentiated spermatogonia) and C‐Kit (a marker for differentiated spermatogonial) in testis sections from wild type mice at the indicated times. The DNA was stained with DAPI. Scale bar = 50 µm. D) Cd164 mRNA levels in GC1 cells infected with either two independent Cd164 siRNA or a scrambled siRNA (Ctrl siRNA). The results are normalized to the Gapdh mRNA level. n = 3, Error bars, S.D. * p < 0.05, ** p < 0.01 by two‐tailed Student's t test. E) GC1 cells stained with Annexin V‐FITC/PI were analyzed by flow cytometry, Q1: dead cells (FITC − /PI + ), Q2: late apoptosis (FITC + /PI + ), Q3: viable cells (FITC − /PI − ), Q4: early apoptosis (FITC + /PI − ). Histogram of the total apoptotic rate in different groups. The total apoptosis rate was defined as late apoptosis plus early apoptosis. n = 3, Error bars, S.D. * p < 0.05 by two‐tailed Student's t test. F) Gene expression patterns of molecules in the apoptosis signaling pathway and the possible mechanism by which CD164 promotes spermatogonia apoptosis. The two‐tailed Student's t test was used to assess significance.

Journal: Advanced Science

Article Title: Deciphering the Molecular Characteristics of Human Idiopathic Nonobstructive Azoospermia from the Perspective of Germ Cells

doi: 10.1002/advs.202206852

Figure Lengend Snippet: CD164 plays an important role in the apoptosis of spermatogonia. A) High‐frequency genes downregulated in spermatogonial stem cells (SSC) of four classes idiopathic nonobstructive azoospermia (iNOA). B) The expression levels of CD164 in human spermatogenesis. The two‐tailed Mann–Whitney–Wilcoxon test was used to assess significance. C) Immunostaining of CD164, LIN28A (a marker for undifferentiated spermatogonia), and SOHLH2 (a marker for differentiated spermatogonia) in testis sections from human adults. The DNA was stained with DAPI. Scale bar = 20 µm. Immunostaining of CD164, Lin28A (a marker for undifferentiated spermatogonia) and C‐Kit (a marker for differentiated spermatogonial) in testis sections from wild type mice at the indicated times. The DNA was stained with DAPI. Scale bar = 50 µm. D) Cd164 mRNA levels in GC1 cells infected with either two independent Cd164 siRNA or a scrambled siRNA (Ctrl siRNA). The results are normalized to the Gapdh mRNA level. n = 3, Error bars, S.D. * p < 0.05, ** p < 0.01 by two‐tailed Student's t test. E) GC1 cells stained with Annexin V‐FITC/PI were analyzed by flow cytometry, Q1: dead cells (FITC − /PI + ), Q2: late apoptosis (FITC + /PI + ), Q3: viable cells (FITC − /PI − ), Q4: early apoptosis (FITC + /PI − ). Histogram of the total apoptotic rate in different groups. The total apoptosis rate was defined as late apoptosis plus early apoptosis. n = 3, Error bars, S.D. * p < 0.05 by two‐tailed Student's t test. F) Gene expression patterns of molecules in the apoptosis signaling pathway and the possible mechanism by which CD164 promotes spermatogonia apoptosis. The two‐tailed Student's t test was used to assess significance.

Article Snippet: After dewaxing and hydration, the sections were boiled in Tris‐EDTA (pH 8.0) for 15 min, gradually cooled down to room temperature, washed in PBST, blocked with 3% BSA for 1 h at room temperature, and then incubated with primary antibodies against CD164 (1:200, GTX17625, GeneTex), Lin28A (1:600, ab46020, abcam), C‐Kit (1:100, D13A2, CST) overnight at 4 °C.

Techniques: Expressing, Two Tailed Test, MANN-WHITNEY, Immunostaining, Marker, Staining, Infection, Flow Cytometry, Gene Expression